UK cushions hospitals reform with medtech-boosting £200 million
This article was originally published in Clinica
The UK has pledged to invest £200m ($323m) over four years as part of a programme to raise standards across the NHS and help hospitals achieve Foundation status. The hospitals most likely to benefit would be those who are short of the three-star performance rating required. The initiative promises to be an important medical technology boost in the priority areas of healthcare on which performance is assessed.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.